| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |